About The Conference

Understanding why and how people carrying pathogenic variants remain free of disease and thus trying to unravel underlying mechanisms of endogenous disease protection of hereditary movement disorders is the overarching theme of the ProtectMove Research Unit. This DFG-funded program project coordinated in Luebeck, Germany, spans the fields of geneticists, molecular and cellular biology, movement disorders, epidemiology and statistics.

The goal of the REDUCED PENETRANCE CONFERENCE is to bring together outstanding international scientists to share data, research ideas and perspectives and to set up new collaborative efforts related to reduced penetrance and, more generally speaking, resilience.

Research Breaktroughs

Penetrance of Movement Disorders Gene Mutations in 20.000 patients and controls.

Large-scale GWAS in dystonia.

Genetic modifiers influencing penetrance and x-linked dystonia-parkinsonism.

Networking Opportunities

Meet the professor.

Networking lunch.

Poster presentations.

Gain New Insights

Mechanisms underlying reduced penetrance.

Exploring the role of the 3D-Genome in penetrance.

Ethics of recall by genotype.

Meet Our Speakers

To view the biographies and abstracts, please click on the photos below.

  • Jan Aasly
    Norwegian University of Science and Technology, Norway
    Talk: "Reduced penetrance in Norwegian LRRK2 mutation carriers".
  • Daniela Berg
    University Hospital Schleswig-Holstein
    Talk: "Reduced penetrance in light of prodromal signs and symptoms of Parkinson’s disease".
  • Matthew Farrer
    University of British Columbia, Canada
    Talk: "Parkinson’s, penetrance and the development of precision medicine”.
  • Andreas Hermann
    German Center for Neurodegenerative Diseases, Germany
    Talk: "Vulnerability vs. reduced penetrance: the selectivity of neurodegeneration".
  • Peter-Robin-Hiesinger
    Free University of Berlin, Germany
    Talk: "The role of intrinsically noisy brain development for reduced penetrance in Drosophila”.
  • Frank-Kaiser
    University of Lübeck
    Conference Co-Chair
  • Christine Klein
    University of Lübeck
    Conference Co-Chair
  • Dimitri Krainc
    Feinberg School of Medicine - Northwestern University, USA,
    Talk: “Mechanistic insights into GBA1-associated Parkinson’s disease: Reduced penetrance or risk factor?”.
  • Alastair Noyce
    Queen Mary University of London, UK
    Talk: "Using Mendelian randomisation to explore causal risk factors and their penetrance for Parkinson’s disease”.
  • McGill University, Canada
    Talk: "Penetrance as a Complex Trait”.
  • Patrik Verstreken
    VIB-KU Leuven Center for Brain & Disease Research, Belgium
    Talk: "Sleep defects in Parkinson’s disease occur with high penetrance”.
  • Richard Youle
    National Institutes of Health, USA
    Talk: "Penetrance of inflammation with Parkin and PINK1 mutant gene dosage”.
Monday, December 10th, 2018

Afternoon Session

Schedule

3:00 – 4:00 pm Registration
4:00 – 4:10 pm Gabriele Gillessen-Kaesbach (President of the University of Luebeck) – Welcome
4:10 – 4:45 pm Christine Klein and Frank Kaiser – Welcome and Introduction into the DFG Research Unit on Reduced Penetrance of Hereditary Movement Disorders
4:45 – 5:30 pm Keynote I
Daniela Berg – Reduced penetrance in light of prodromal signs and symptoms of Parkinson’s disease
5:30 – 6:15 pm Keynote II
Constantin Polychronakos – Reduced penetrance in light of prodromal signs and symptoms of Parkinson’s diseasen Polychronakos – Penetrance as a Complex Trait
 6:15 – 6:30 pm Closing remarks by Christine Klein and Frank Kaiser
   
   
   
Tuesday, December 11th, 2018

Morning Session

Schedule

9:00 – 9:30 am Welcome and update by Christine Klein and Frank Kaiser
9:30 – 10:15 am Introduction Lecture I: Matt Farrer – Parkinson’s, penetrance and the development of precision medicine
10:15 – 11:00 am Introduction Lecture II: Dimitri Krainc – Mechanistic insights into GBA1-associated Parkinson’s disease: Reduced penetrance or risk factor?
11:00 – 11:30 am Coffee break
11:30 – 12:15 am Richard Youle – Penetrance of inflammation with Parkin and PINK1 mutant gene dosage
12:15 – 1:00 pm Alastair Noyce – Using Mendelian randomization to explore causal risk factors and their penetrance for Parkinson’s disease
1:00 – 2:30 pm Lunch
Tuesday, December 11th, 2018

Afternoon Session

Schedule

2:30 – 3:15 pm Robin Hiesinger – The role of intrinsically noisy brain development for reduced penetrance in Drosophila
3:15 – 4:00 pm Patrik Verstreken – Sleep defects in Parkinson’s disease occur with high penetrance
4:00 – 4:30 pm Coffee break
4:30 – 5:15 pm Andreas Herrmann – Vulnerability vs. reduced penetrance: the selectivity of neurodegeneration
5:15 – 6:00 pm Jan Aasly – Reduced penetrance in Norwegian LRRK2 mutation carriers
6:00 – 6:15 pm Closing remarks by Christine Klein and Frank Kaiser
7:30 pm Dinner at „Ratskeller zu Lübeck“
www.ratskeller-zu-luebeck.de
RESERVATIONS

Katja Herrmann-Malzahn
Institute of Neurogenetics
University of Lübeck
+49 451-3101-7491

katja.herrmannmalzahn@uni-luebeck.de

ORGANIZATION

Dr. Michaela Trilck-Winkler
Institute of Neurogenetics
University of Lübeck
+49 451-3101-8203

michaela.trilck@neuro.uni-luebeck.de

Conference Will Start in

Conference Fee

Registration fees: 100,00 EUR

Registration fees (dinner included): 140,00 EUR

Registration fees for students: 50,00 EUR

Registration fees for students (dinner included): 75,00 EUR

 

Payment

The registration fee may be paid by bank transfer:

Universitätsklinikum Schleswig-Holstein
Deutsche Bank Lübeck
IBAN: DE30 2307 0710 0872 0815 00
SWIFT/BIC: DEUT DE HH 222
Payment reference: F275090 „reduced penetrance Conference 2018“

Venue

Radisson Blu Senator Hotel, Willy-Brandt-Allee 6, 23554 Lübeck, Germany

Conference room “Lübeck 1 + 2”

Funding & Partners